Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia

Journal of Anxiety Disorders

Volumn 16, Issue 3, 2002, Pages 233-246

  Westra, Henny A ^a   Stewart, Sherry H ^b   Conrad, Brent E ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Benzodiazepines (BZs); Cognitive behavioral therapy (CBT); Panic disorder

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MALE; PANIC; SYMPTOMATOLOGY; TREATMENT OUTCOME; DRUG SELF ADMINISTRATION; MULTIMODALITY CANCER THERAPY;

ADULT; AGORAPHOBIA; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMAN; MALE; PANIC DISORDER; SELF ADMINISTRATION; TREATMENT OUTCOME; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; HUMANS;

EID: 0036020266     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-6185(02)00091-9     Document Type: Article

References (40)

1. Alprazolam in panic disorder and agoraphobia: Results from a multi-center trial
2. An inventory for measuring clinical anxiety: Psychometric properties
3. An inventory for measuring depression
4. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder
5. Drug treatment of panic disorder: The comparative efficacy of imipramine, alprazolam, and trazadone
6. A meta-analysis of treatments for panic disorder
7. An integrated approach to panic disorder
8. Tranquilizing memories: A review of the effects of benzodiazepines on human memory
9. Benzodiazepines, memory and mood: A review
10. Cognitive behavioral and pharmacological treatments of social phobia: A controlled study
11. Normative values for the Beck Anxiety Inventory, Fear Questionnaire, Panic State Worry Questionnaire, and social phobia and anxiety inventory
12. A meta-analysis of treatment outcome for panic disorder
13. Benzodiazepine self-administration in humans and laboratory animals - Implications for problems of long-term use and abuse
14. Exposure in vivo of agoraphobics: Contributions of diazepam, group exposure, and anxiety evocation
15. Combined cognitive behavioral and time-limited alprazolam treatment of panic disorder
16. Brief standard rating for phobic avoidance
17. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto
18. Enhanced relief of phobias by flooding during waning diazepam effect
19. Automaticity and the anxiety disorders
20. Group cognitive behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: A clinical case series
21. Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment
22. Long-term alprazolam use: Abuse, dependence or treatment?
23. Clinical aspects of chronic use of alprazolam and lorazepam
24. Interactions of benzodiazepines with psychological and behavioral treatment
25. Panic disorder: Cognitive behavioral and pharmacological treatment strategies
26. Discontinuation symptoms among persistent alprazolam users
27. Standardized assessment for panic disorder research
28. Effects of naturalistic benzodiazepine use on selective attention to threat cues among anxiety disorder patients
29. Behavior therapy and benzodiazepines: Allies or antagonists?
30. Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia
31. Cognitive behavioral therapy and pharmacotherapy: Complementary or contradictory approaches to the treatment of anxiety?
32. As-needed administration of benzodiazepines: Incidence and implications